Last reviewed · How we verify
NCT02474160
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
trial testing Cytology Specimen Collection Procedure in Hematopoietic and Lymphatic System Neoplasm in 5,000 participants. Currently enrolling.
4 May 2026
Quick facts
| Lead sponsor | National Cancer Institute LAO |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 19 May 2015 |
| Primary completion | 4 May 2026 |
| Estimated completion | 4 May 2026 |
| Sites | 140 locations across United States |
Drugs / interventions tested
- Cytology Specimen Collection Procedure
Conditions studied
- Hematopoietic and Lymphatic System Neoplasm — all drugs for Hematopoietic and Lymphatic System Neoplasm →
- Malignant Solid Neoplasm — all drugs for Malignant Solid Neoplasm →
- Metastatic Malignant Solid Neoplasm — all drugs for Metastatic Malignant Solid Neoplasm →
- Recurrent Malignant Solid Neoplasm — all drugs for Recurrent Malignant Solid Neoplasm →
Sponsor
National Cancer Institute LAO
Who can join
2 Months and older, any sex, with Hematopoietic and Lymphatic System Neoplasm or Malignant Solid Neoplasm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study collects and stores tissue and blood samples from patients with cancer. Collecting and storing samples of tissue and blood from patients with cancer to study in the laboratory may help scientists create new and better models to learn about cancer and to test new cancer drugs.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02474160
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cytology Specimen Collection Procedure
Trials testing the same drug.
- NCT04142385 — Incidence of HIV Infection in Screening Indian Men Who Have Sex With Men · withdrawn
- NCT04142398 — Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men · withdrawn
- NCT04526587 — Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors · recruiting
- NCT02514408 — Circulating Tumor Cells in Operative Blood in Patients With Bladder Cancer · withdrawn
- NCT03057626 — Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma · active not recruiting
Other recruiting trials for Hematopoietic and Lymphatic System Neoplasm
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT07020533 — A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Pa · Phase 1 · recruiting
- NCT07141407 — Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and T · NA · recruiting
- NCT06565260 — Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors · NA · recruiting
- NCT07220447 — L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance · EARLY_PHASE1 · recruiting
Other National Cancer Institute LAO trials
Trials by the same sponsor.
- NCT05836571 — Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft T · Phase 2 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02474160 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Cancer Institute LAO
- Last refreshed: 5 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02474160.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing